FI9608U1 - Formulaatiot - Google Patents

Formulaatiot

Info

Publication number
FI9608U1
FI9608U1 FI20114160U FIU20114160U FI9608U1 FI 9608 U1 FI9608 U1 FI 9608U1 FI 20114160 U FI20114160 U FI 20114160U FI U20114160 U FIU20114160 U FI U20114160U FI 9608 U1 FI9608 U1 FI 9608U1
Authority
FI
Finland
Prior art keywords
formulations
Prior art date
Application number
FI20114160U
Other languages
English (en)
Swedish (sv)
Inventor
Peter Stein
Ian Cox
Samuel Smith
Leighton Jones
Joerg Plessl
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1018648.4A external-priority patent/GB201018648D0/en
Priority claimed from DE202010016235U external-priority patent/DE202010016235U1/de
Priority claimed from AU2011100528A external-priority patent/AU2011100528B4/en
Application filed by Norgine Bv filed Critical Norgine Bv
Application granted granted Critical
Publication of FI9608U1 publication Critical patent/FI9608U1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
FI20114160U 2010-11-04 2011-11-04 Formulaatiot FI9608U1 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018648.4A GB201018648D0 (en) 2010-11-04 2010-11-04 Formulations
DE202010016235U DE202010016235U1 (de) 2010-12-06 2010-12-06 Formulierungen
AU2011100528A AU2011100528B4 (en) 2011-05-10 2011-05-10 Formulations

Publications (1)

Publication Number Publication Date
FI9608U1 true FI9608U1 (fi) 2012-03-29

Family

ID=45689078

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20114160U FI9608U1 (fi) 2010-11-04 2011-11-04 Formulaatiot

Country Status (5)

Country Link
AT (1) AT12928U1 (fi)
DK (1) DK201100161U3 (fi)
FI (1) FI9608U1 (fi)
FR (1) FR2967069B3 (fi)
IE (1) IES20110480A2 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3056109B1 (fr) * 2016-09-21 2019-10-11 Pierre Fabre Medicament Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001748B1 (en) * 1997-07-25 2006-04-19 Alpex Pharma S.A. A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
WO2007057924A1 (en) * 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala

Also Published As

Publication number Publication date
IES20110480A2 (en) 2012-07-18
FR2967069B3 (fr) 2012-11-16
DK201100161U3 (da) 2012-02-24
AT12928U1 (de) 2013-02-15
FR2967069A3 (fr) 2012-05-11

Similar Documents

Publication Publication Date Title
DK2648809T3 (da) Naturlige formuleringer
DK3170508T3 (da) Vaccineformuleringer
BR112012028556A2 (pt) Indóis
CR20130111A (es) Triazina-oxidiazoles
DE102011100241A8 (de) Nitridhalbleiterbauteil
DK3225404T3 (da) Fluidpatron
DE10170954T8 (de) Mikrowellendruckgarer
DE112011104226A5 (de) Käfigmutter
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
DE112011102080A5 (de) Kupplungszentralausrücker
DE112011101226A5 (de) Linearwegmesssystem
DK2442899T3 (da) Rotorskive
DK2539163T3 (da) Dækventil
DE102011002623A8 (de) Ventilsteuerzeitversteller
DE112011102711A5 (de) Hydrostataktor
DE102010019119B8 (de) Cuttermesser
DE112010005518A5 (de) Dichtungsmanchette
DE102010038420A8 (de) Reinigungungsvorrichtung
DK2596072T3 (da) Bor-forbindelses-suspension
DK2521486T3 (da) Palpometer
DE102010035554B8 (de) Fußtüröffner
CO6801789A2 (es) N-hetarilmetil pirazolilcarboxamidas
DK2672817T3 (da) Forbedrede insekticide formuleringer
DE112011101796A5 (de) Redoxakkumulatoranlage
DK2404809T3 (da) Trækbjælke

Legal Events

Date Code Title Description
FGU Utility model registered

Ref document number: 9608

Country of ref document: FI

Kind code of ref document: U1

MMU Utility model lapsed